报价延迟最少15分钟:2025/10/23 16:15 EDT
盘后时段
|
||||
|
15.43 
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
15.43
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.57/-0.54
|
|
企业价值
700.70M
|
| 资产负债 |
|
每股账面净值
3.95
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
167.18M
|
|
每股收益
3.06
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
报价延迟最少15分钟：2025/10/23 16:15 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. |
